Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Camp

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
The British Journal of Dermatology|July 1, 1985
The role of chemo-attractant lipoxygenase products in the pathogenesis of psoriasisR D Camp, A I Mallet, F M Cunningham, et al.
Dermatology (Basel, Switzerland)|September 11, 2001
Cyclosporin for atopic dermatitis in childrenJ I Harper, J Berth-Jones, R D Camp, et al.
Human Molecular Genetics|May 1, 1997
Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasisR C Trembath, R L Clough, J L Rosbotham, et al.
Lancet (London, England)|July 20, 1991
Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitisJ M Sowden, J Berth-Jones, J S Ross, et al.
The British Journal of Dermatology|October 1, 1993
Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trialM S Salek, A Y Finlay, D K Luscombe, et al.
The British Journal of Dermatology|January 1, 1997
Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitisJ Berth-Jones, R A Graham-Brown, R Marks, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
The British Journal of Dermatology|July 1, 1985
The role of chemo-attractant lipoxygenase products in the pathogenesis of psoriasisR D Camp, A I Mallet, F M Cunningham, et al.
Dermatology (Basel, Switzerland)|September 11, 2001
Cyclosporin for atopic dermatitis in childrenJ I Harper, J Berth-Jones, R D Camp, et al.
Human Molecular Genetics|May 1, 1997
Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasisR C Trembath, R L Clough, J L Rosbotham, et al.
Lancet (London, England)|July 20, 1991
Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitisJ M Sowden, J Berth-Jones, J S Ross, et al.
The British Journal of Dermatology|October 1, 1993
Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trialM S Salek, A Y Finlay, D K Luscombe, et al.
The British Journal of Dermatology|January 1, 1997
Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitisJ Berth-Jones, R A Graham-Brown, R Marks, et al.
Pageof 8